Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Fluconazole in Invasive Candidiasis and Candidaemia
NCT00189709Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of micafungin in invasive candidiasis, candidemia, sponsored by Astellas Pharma. Started Aug 2004; status: completed.
02
Drugs
micafungin
03
Conditions
invasive candidiasiscandidemia
Beyond the preview
Go deeper on NCT00189709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189709.